Clinical Study

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer

Figure 3

QLQ-C30 Global health status and functional scores.
862921.fig.003a
(a)
862921.fig.003b
(b)
862921.fig.003c
(c)
862921.fig.003d
(d)
862921.fig.003e
(e)
862921.fig.003f
(f)